Gastrointestinal disorders
19 results
Applied filters
Considering sodium content of medicines
24 December 2021High sodium content can make some medicines unsuitable for patients on a salt-restricted diet. Alternative products exist for a range of conditions.
Treating heartburn and dyspepsia during breastfeeding
5 March 2024Antacids, alginates, H2-receptor antagonists or proton pump inhibitors can be used during breastfeeding. Recommendations are for full term and healthy infants.
Preparing to use golimumab biosimilar
9 January 2026One golimumab biosimilar (Gobivaz) is available. We offer general information and implementation advice.
PPI suggestions for adults with swallowing difficulties
18 December 2025A range of proton pump inhibitor (PPI) formulations are suitable for adults with swallowing difficulties.
Haemorrhoids: treatment during pregnancy
4 March 2025Use non-pharmacological treatment for the management of haemorrhoids during pregnancy. If insufficient use a topical haemorrhoidal preparation.
Treating nausea during breastfeeding
26 March 2024Some anti-emetics can be used with caution during breastfeeding, depending on the clinical situation. Recommendations apply to full term, healthy infants.
Treating rectal and anal disorders during breastfeeding
19 March 2024Rectal and anal topical preparations for haemorrhoids and anal fissures are compatible with breastfeeding. Recommendations apply to full term, healthy infants.
Using gastrointestinal antispasmodics during breastfeeding
8 March 2024Hyoscine butylbromide, propantheline or peppermint oil are preferred choices during breastfeeding. Recommendations apply to full term and healthy infants.
Preparing to use ustekinumab biosimilar
29 July 2025Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
Good governance when implementing ustekinumab biosimilar
29 July 2025Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.